ODDB.org: Open Drug Database

Mepha Pharma AG - Rivaroxaban-Mepha 20 mg, Filmtabletten

Swissmedic Registration	68439	Sequence	03
Product name	Rivaroxaban-Mepha 20 mg	Description	Filmtabletten
ATC-Classification	B01AF01	ATC-Description	Rivaroxaban
Introduction of Sequence	15.03.2022

Composition

rivaroxabanum 20 mg, natrii laurilsulfas, lactosum monohydricum 167.2 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.19 mg.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Rivaroxabanum	20 mg

BAG: Active Agent	Dose
Rivaroxabanum	20 mg

Inactive agents	Dose	additional_information
(Rubrum)
Carmellosum Natricum Conexum
E 172		color.
Hypromellosum
Lactose Monohydrate	167.2 mg
Macrogol	3350
Magnesii Stearas
Natrii Laurilsulfas
Poly(Alcohol Vinylicus)		Überzug
Pro Compresso Obducto
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
008	14	7.25	24.45	B	SL	No
009	28	14.08	32.00	B	SL	No
010	98	51.65	73.70	B	SL	No
011	100	52.70	74.75	B	SL	No

2025	©ywesee GmbH